Overview of listed company good news on the evening of February 23 ( with list )

Shanghai and Shenzhen listed companies released important announcements on the evening of February 23. Below is a summary of the positive news:

Qianyan Biotech: Signs Exclusive Licensing Agreement with GlaxoSmithKline

Qianyan Biotech announced that the company has reached an exclusive licensing agreement with global biopharmaceutical company GlaxoSmithKline (GSK). Under the agreement, GSK will obtain exclusive rights worldwide to develop, produce, and commercialize two small nucleic acid (siRNA) pipeline products, one of which has entered IND (Investigational New Drug) application stage, and the other is a preclinical candidate. The company will receive a $40 million upfront payment and a $13 million milestone payment in the near term; additionally, the company will potentially earn up to $950 million in success-based milestone payments related to development, regulatory approval, and commercialization, along with tiered royalties on global net sales of the two products. The company will be responsible for early development of the two products, including advancing one product’s Phase I clinical trial in China and completing IND-supporting studies for the other. GSK will handle all subsequent global clinical development, regulatory filings, and commercialization activities.

Tongce Medical: Chairman and Others Plan to Increase Holdings by 6 to 12 Million Yuan

Tongce Medical announced that on February 13, 2026, Chairman Wang Yi increased his holdings by 10,500 shares, amounting to 499,600 yuan; Director Huang Yuhua increased by 10,000 shares, amounting to 476,050 yuan; Secretary Zhang Hua increased by 10,000 shares, amounting to 473,300 yuan; other management personnel Zhao Min increased by 7,700 shares, amounting to 367,100 yuan. The company’s directors and senior executives plan to, within six months from the date of this purchase, increase their holdings of the company’s shares through centralized bidding, totaling no less than 6 million yuan and no more than 12 million yuan (including the amount of shares purchased on February 13, 2026).

Kede CNC: Controlling Shareholder, Actual Controller, and General Manager Promise Not to Reduce Holdings in Next 6 Months

Kede CNC announced that its controlling shareholder Guangyang Technology, actual controllers Yu Dehai and Yu Benhong, and General Manager Chen Hu voluntarily committed that from February 23, 2026, for the next six months, they will not reduce their direct or indirect holdings of the company’s shares by any means. Shares increased due to company’s issuance of bonus shares, capital increase, rights issue, etc., during this period will also adhere to this non-reduction commitment, excluding shares repurchased and canceled under stock incentive plans.

Luxshare Precision: First Repurchase of 9.9006 Million Shares, Cost Nearly 500 Million Yuan

Luxshare Precision announced that on February 13, 2026, the company repurchased 9.9006 million shares through a dedicated share repurchase account via centralized bidding, representing 0.14% of total share capital as of February 12, 2026. The highest transaction price was 50.91 yuan per share, the lowest was 50.14 yuan per share, with a total transaction amount of nearly 500 million yuan (excluding transaction fees).

Shuangliang Energy Saving: Subsidiary Wins 100 Million Yuan H-Class Combined Cycle Power Plant Project

Shuangliang Energy Saving announced that its wholly owned subsidiary Jiangsu Shuangliang Cooling System Co., Ltd. recently won the bid for the air-cooling island (ACC) system of an H-class combined cycle power plant in the Middle East, with an estimated bid amount of 100 million yuan, accounting for 0.77% of the company’s audited operating revenue in 2024. The project mainly involves design, procurement, construction, and commissioning of the combined cycle power plant.

Donghong Co.: Wins 353 Million Yuan Pressure Steel Pipe and Fittings Project

Donghong Co. announced that it recently received a winning notice, confirming the company as the successful bidder for a pressure steel pipe and fittings procurement project, with a bid price of 353 million yuan.

Jin Tanglang: Subsidiary Wins Malaysia Sabah Intercontinental Resort Hotel Project

Jin Tanglang announced that its subsidiary Jin Tanglang Construction & Decoration (Malaysia) Co., Ltd., as the designated subcontractor for the project, successfully won the bid for the Malaysia Sabah Intercontinental Resort Hotel project, with a bid amount approximately 281 million yuan, accounting for 1.53% of the company’s audited operating revenue in 2024. The project is expected to positively impact the company’s business development and operating performance, and help enhance its brand influence and market recognition in the high-end hotel decoration sector overseas.

Jiayou International: Zambia Endora to Sakania Road Section Officially in Commercial Operation and Tolling Begins

Jiayou International announced that on February 22, 2026, after joint acceptance by relevant departments and approval by the Zambia Cabinet, the 17.26 km road section from Endora to Sakania, including toll stations and related facilities, obtained the “Certificate of Practical Completion” and “Toll License,” officially entering commercial operation and starting toll collection. The successful acceptance and tolling of this road section mark an important milestone for Zambia’s Sakania PPP project, signifying the company’s first PPP project in Zambia moving from investment to operation, generating stable income, and facilitating the faster and smoother implementation of the remaining parts of the project.

(Source: Oriental Fortune Research Center)